Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis

Critical Reviews in Clinical Laboratory Sciences

Volumn 39, Issue 3, 2002, Pages 225-283

  Hannuksela, Minna L ^a   Liisanantti, Marja K ^a   Savolainen, Markku J ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Apolipoproteins; Arteriosclerosis; Chylomicrons; Endothelium, vascular, ethanol; Lipoproteins, HDL; Lipoproteins, IDL; Lipoproteins, LDL; Lipoproteins, VLDL

Indexed keywords

ACETALDEHYDE; ALCOHOL; APOLIPOPROTEIN; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL ESTER TRANSFER PROTEIN; FATTY ACID ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPASE; PHOSPHOLIPID TRANSFER PROTEIN;

ALCOHOL CONSUMPTION; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; REVIEW; ARTERIOSCLEROSIS; BLOOD; DRINKING BEHAVIOR; METABOLISM;

ALCOHOL DRINKING; ARTERIOSCLEROSIS; HUMAN; LIPIDS; LIPOPROTEINS; HUMANS;

EID: 0035991728     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408360290795529     Document Type: Review

References (385)

1. Alcohol and cardiovascular disease: The status of the U shaped curve
2. The relationship between alcohol and coronary heart disease: Is there a protective effect?
3. Epidemiology of coronary heart disease - Influence of alcohol
4. Alcohol and coronary heart disease: Consistent relationship and public health implications
5. Alcohol and coronary heart disease: The evidence for a protective effect
6. Alcohol intake and cardiovascular morbidity and mortality
7. Alcohol consumption and stroke incidence in male smokers
8. Alcohol and stroke: A community case-control study in Asturias, Spain
9. Alcohol and ischemic stroke
10. Alcohol intake and the risk of stroke
11. Alcohol, coronary heart disease and stroke: An examination of the J-shaped curve
12. Are risk factors for stroke and coronary disease the same?
13. Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors
14. Effects of alcohol on lipoproteins in relation to coronary heart disease
15. Alcohol and lipids
16. High-density lipoprotein - The clinical implications of recent studies
17. High density lipoproteins and coronary heart disease
18. Epidemiological aspects of high density lipoprotein cholesterol
19. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease
20. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: Results form the Lipid Research Clinics Follow-up study
21. Acetaldehyde modification of low density lipoprotein accelerates its catabolism in man
22. Acetaldehyde binding increases the catabolism of rat serum low-density lipoproteins
23. Acetaldehyde adducts and autoantibodies against VLDL and LDL in alcoholics
24. An abnormal phospholipid in rat organs after ethanol treatment
25. Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol
26. Cytotoxicity of short-chain alcohols
27. Atherosclerosis - An inflammatory disease
28. Atherosclerosis
29. Lipoprotein separation and analysis for clinical studies
30. Apolipoproteins and lipoproteins in human plasma
31. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium
32. Postprandial lipoproteins and atherosclerosis
33. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma
34. Chylomicron-remnant-induced foam cell formation and cytotoxicity: A possible mechanism of cell death in atherosclerosis
35. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: Case control study over three years
36. Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man
37. Ethanol with a mixed meal increases postprandial triacylglycerol but decreases postprandial non-esterified fatty acid concentrations
38. Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia
39. Relationship of alcoholic hypertriglyceridemia to stage of liver disease and dietary lipid
40. Effect of chronic ethanol feeding upon the catabolism of protein and lipid moieties of chylomicrons and very low density lipoproteins in vivo and in the perfused heart system
41. Lipoprotein subclasses and atherosclerosis
42. Accelerated turnover of very low density lipoprotein triglycerides in chronic alcohol users. A possible mechanism for the up-regulation of high density lipoprotein by ethanol
43. Pathogenesis of the hypertriglyceridemia at early stages of alcoholic liver injury in the baboon
44. Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal men
45. Sequence of alcohol-induced initial changes in plasma lipoproteins (VLDL and HDL) and lipolytic enzymes in humans
46. High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal
47. Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake
48. Effect of apolipoprotein E phenotype on plasma lipids and lipoproteins in alcohol abusers
49. Comparison of the effects of two different doses of alcohol on serum lipoproteins, HDL-subfractions and apolipoproteins A-I and A-II: A controlled study
50. Multiple changes in apoprotein B containing lipoproteins after ethanol withdrawal in alcoholic men
51. Apolipoprotein(a): Structure and biology
52. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study
53. Exercise-induced increase in lipoprotein (a)
54. Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: Population based study
55. Dose-dependent inverse relationship between alcohol consumption and serum Lp(a) levels in black African males
56. Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: Determinant effect on heart disease?
57. A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men
58. The effect of alcohol withdrawal on serum concentrations of Lp(a), apolipoproteins A-1 and B, and lipids
59. Serum lipoprotein(a) [Lp(a)] in alcoholic men: Effect of withdrawal
60. A controlled trial of the effects of pattern of alcohol intake on serum lipid levels in regular drinkers
61. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II
62. Heterogeneity of high density lipoprotein particles
63. The Tromso heart-study. High-density lipoprotein and coronary heart-disease: A prospective case-control study
64. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study
65. High density lipoprotein cholesterol and incidence of coronary heart disease - The Israeli Ischemic Heart Disease study
66. High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: A prospective case-control study in middle-aged men of the Oslo study
67. Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease
68. HDL cholesterol and mortality in Finnish men with special reference to alcohol intake
69. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease
70. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men
71. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins
72. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects
73. High-density lipoprotein subfractions in normolipidemic patients with coronary atherosclerosis
74. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction
75. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction
76. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles
77. Apolipoprotein A-I containing lipoproteins in coronary artery disease
78. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
79. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
80. Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma
81. The effect of cessation and resumption of moderate alcohol intake on serum high-density lipoprotein subfractions. A controlled study
82. The relationship of high-density lipoprotein subfractions to alcohol consumption, other lifestyle factors, and coronary heart disease
83. Relationship of alcohol consumption to changes in HDL subfractions
84. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation
85. Alcohol consumption and its relation to lipid-based cardiovascular risk factors among middle-aged women: The role of HDL(3) cholesterol
86. Associations of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: The Stanford Five City Project
87. Effect of alcohol intake on human apolipoprotein A-I-containing lipoprotein subfractions
88. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII
89. Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men
90. Effects of alcohol consumption on lipoproteins of premenopausal women. A controlled diet study
91. The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a)
92. Cardiovascular risk factors and alcohol consumption in France and Northern Ireland
93. Association of alcohol consumption with HDL subpopulations defined by apolipoprotein A-I and apolipoprotein A-II content
94. High density lipoprotein subfractions, apolipoprotein A-I containing lipoproteins, lipoprotein (a), and cholesterol ester transfer protein activity in alcoholic women before and after ethanol withdrawal
95. Alcohol consumption and high density lipoprotein cholesterol concentration among alcoholics
96. Lipoprotein composition influences cholesteryl ester transfer in alcohol abusers
97. Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity
98. Moderate doses of alcoholic beverages with dinner and postprandial high density lipoprotein composition
99. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients
100. Changes in postprandial lipoproteins of low and high density caused by moderate alcohol consumption with dinner
101. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers
102. Concentrations of apolipoprotein AI, AII, and E in plasma and lipoprotein fractions of alcoholic patients: Gender differences in the effects of alcohol
103. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II
104. Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity
105. High-density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers
106. Effect of alcohol intake on high and low density lipoprotein metabolism in healthy volunteers
107. Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: Implications for a mechanism for atherosclerosis protection
108. Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity
109. Alcohol delays clearance of lipoproteins from the circulation
110. Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease resulting from alcohol abuse: Effects of alcohol intake cessation
111. Post-heparin lipolytic activities and alterations of the chemical composition of high density lipoproteins in alcohol-induced type V hyperlipidemia
112. Alcohol: High density lipoproteins, apolipoproteins
113. Apolipoprotein E in alcoholics
114. High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function
115. The effect of age and lifestyle factors on plasma levels of apolipoprotein E
116. Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations
117. The effects of alcohol on coagulation and fibrinolytic factors: A controlled trial
118. Abstinence-induced changes in plasma apolipoprotein levels of alcoholics
119. Abnormal low density lipoproteins composition in some chronic alcoholics: A possible mechanism
120. Effects of alcohol and cholesterol feeding on lipoprotein metabolism and cholesterol absorption in rabbits
121. Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits
122. Wine, beer and spirits and the risk of myocardial infarction: A systematic review
123. Type of alcohol and mortality from cardiovascular disease
124. High-density-lipoprotein cholesterol and types of alcoholic beverages consumed among men and women
125. Diet, alcohol and health: A story of connections, confounders, and cofactors
126. Mortality associated with moderate intakes of wine, beer, or spirits
127. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability
128. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine
129. The effect of whisky and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers
130. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation
131. Red wine consumption inhibits LDL oxidation and aggregation in humans and in atherosclerotic mice
132. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo
133. The role of alcohol in the anti low-density lipoprotein oxidation activity of red wine
134. Red wine inhibits the cell-mediated oxidation of LDL and HDL
135. Inhibition of human LDL lipid peroxidation by phenol-rich beverages and their impact on plasma total antioxidant capacity in humans
136. Wine and polyphenols related to platelet aggregation and atherothrombosis
137. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide
138. Moderate consumption of beer, red wine and spirits has counteracting effects on plasma antioxidants in middle-aged men
139. Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice
140. Red wine mitigates the postprandial increase of LDL susceptibility to oxidation
141. Alcohol consumption, diet, coronary risk factors, and prevalent coronary heart disease in men and women in the Scottish heart health study
142. Wine intake and diet in a random sample of 48763 Danish men and women
143. Alcohol beverage drinking, diet and body mass index in a cross-sectional survey
144. Psychosocial and socio-economic factors in women and their relationship to obesity and regional body fat distribution
145. Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME study. Prospective Epidemiological Study of Myocardial Infarction study
146. Alcohol drinking and cigarette smoking: An exploration of the association in middle-aged men and women
147. Beer, wine, spirits and subjective health
148. Effects of drinking patterns on the relationship between alcohol an coronary occlusion
149. Effect of drinking pattern on plasma lipoproteins and body weight
150. Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors - A review
151. Alcohol consumption and sudden coronary death in middle-aged Finnish men
152. Alcohol and cardiovascular mortality in Moscow; new evidence of a causal association
153. Beer binging and mortality: Results from the Kuopio ischaemic heart disease risk factor study, a prospective population based study
154. Frequent hangovers and cardiovascular mortality in middle-aged men
155. Ethanol intoxication: A risk factor for ischemic brain infarction
156. Regular light-to-moderate intake of alcohol and the risk of ischemic stroke. Is there a beneficial effect?
157. Recent alcohol consumption, cigarette smoking, and cerebral infarction in young adults
158. Recent heavy drinking of alcohol and embolic stroke
159. Sex differences in high density lipoprotein cholesterol among low-level alcohol consumers
160. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors
161. Sex difference in high density lipoprotein cholesterol in six countries
162. Smoking and plasma lipoprotein metabolism
163. Smoking, alcohol and lipoprotein metabolism
164. The effects of cigarette smoking and alcohol consumption on blood lipids: A dose-related study on men
165. Non-pharmacological modification of cardiac risk factors: Part 3. Smoking cessation and alcohol consumption
166. Influence of sex, age, body mass index, and smoking on alcohol intake and mortality
167. Cigarette smoking is associated with unhealthy patterns of nutrient intake: A meta-analysis
168. Changes in women's plasma lipid and lipoprotein concentrations due to moderate consumption of alcohol are affected by dietary fat level
169. The effect of moderate physical exercise on the plasma lipoprotein subfractions of male survivors of myocardial infarction
170. Does weight loss cause the exercise-induced increase in plasma high density lipoproteins?
171. Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in women
172. Interactive effects of exercise, alcohol, and vegetarian diet on coronary artery disease risk factors in 9242 runners: The National Runners' Health study
173. Effect of alcohol and exercise on postprandial lipemia and triglyceride clearance in men
174. High-density lipoprotein cholesterol in male alcoholics with and without severe liver disease
175. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: On the relative roles of alcohol and liver injury
176. Variations in HDL and VLDL levels chronic alcoholics. Influence of the degree of liver damage and of withdrawal of alcohol
177. Lecithin-cholesterol acyltransferase and lipid transfer protein activities in liver disease
178. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers
179. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction
180. APO E gene and gene-environment effects on plasma lipoprotein-lipid levels
181. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis
182. Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: The Framingham Offspring study
183. Apolipoprotein E polymorphism in middle-aged Belgian men: Phenotype distribution and relation to serum lipids and lipoproteins
184. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: The Bogalusa Heart study
185. Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men
186. HDL, its enzymes and its potential to influence lipid peroxidation
187. The antiatherogenic role of high-density lipoprotein cholesterol
188. Atheroprotective mechanisms of HDL
189. Moderate alcohol consumption: Effects on lipids and cardiovascular disease risk
190. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport
191. Beneficial effects of a moderate consumption of red wine on cellular cholesterol efflux in young men
192. Cholesterol efflux to high-density lipoproteins and apolipoprotein A-I phosphatidylcholine complexes is inhibited by ethanol: Role of apolipoprotein structure and cooperative interaction of phosphatidylcholine and cholesterol
193. Effect of dietary omega-3 fatty acids and chronic ethanol consumption on reverse cholesterol transport in rats
194. Effects of alcohol on the major steps of reverse cholesterol transport
195. HDL3 stimulates multiple signaling pathways in human skin fibroblasts
196. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1
197. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine
198. Oxidized LDL and HDL: Antagonists in atherothrombosis
199. The oxidative modification hypothesis of atherosclerosis: Does it hold for humans?
200. Antioxidant effect of ethanol toward in vitro peroxidation of human low-density lipoproteins initiated by oxygen free radicals
201. Oxidative susceptibility of low-density lipoproteins - Influence of regular alcohol use
202. Serum low density lipoprotein of alcoholic patients is chemically modified in vivo and induces apolipoprotein E synthesis by macrophages
203. Oxidation of LDL in baboons is increased by alcohol and attenuated by polyenylphosphatidylcholine
204. Lipid peroxidation as a mechanism of alcoholic liver injury: Role of iron mobilization and microsomal induction
205. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators
206. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low-density lipoproteins to oxidative modification
207. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects
208. Dilinoleoylphosphatidylcholine protects human low-density lipoproteins against oxidation
209. Dilinoleoylphosphatidylcholine is the active antioxidant of polyenylphosphatidylcholine
210. Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon
211. Polyenylphosphatidylcholine decreases alcoholic hyperlipemia without affecting the alcohol-induced rise of HDL-cholesterol
212. Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats
213. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon
214. How does alcohol raise HDL-cholesterol concentration?
215. Effects of chronic ethanol intake on mobilization and excretion of cholesterol in baboons
216. Ethanol induced alterations in low and high density lipoproteins
217. Roles of plasma lipid transfer proteins in reverse cholesterol transport
218. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol
219. Evaluation of plasma cholesteryl ester transfer protein (CETP) activity as a marker of alcoholism
220. CETP and LCAT activities are unrelated to smoking and moderate alcohol consumption in healthy normolipidemic men
221. Higher high density lipoprotein cholesterol associated with moderate alcohol consumption is not related to altered plasma lecithin:cholesterol cyltransferase and lipid transfer protein activity levels
222. CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese
223. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity
224. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men
225. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels
226. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations
227. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
228. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F
229. Cholesteryl ester transfer protein and its plasma regulator: Lipid transfer inhibitor protein
230. Suppression of lipid transfer inhibitor protein activity by oleate. A novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acids
231. The impact of phospholipid transfer protein (PLTP) on HDL metabolism
232. Lecithin cholesterol acyltransferase
233. Alterations in high-density lipoprotein subfractions during postprandial lipidaemia induced by fat with and without ethanol
234. Lipoprotein lipase: Physiology, biochemistry, and molecular biology
235. Hepatic lipase and HDL metabolism
236. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase
237. High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis
238. Does paraoxonase play a role in susceptibility to cardiovascular disease?
239. Human plasma platelet-activating factor acetylhydrolase
240. Paraoxonase and atherosclerosis
241. Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomized intervention study in middle-aged men
242. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor
243. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice
244. Relative sensitivities of plasma lecithin:cholesterol acyltransferase, platelet-activating factor acetylhydrolase, and paraoxonase to in vitro gasphase cigarette smoke exposure
245. Acid phospholipase A1 in liver - A brief survey
246. Apolipoprotein B exhibits phospholipase A1 and phospholipase A2 activities
247. Cytosolic phospholipase A2
248. Diversity of group types, regulation, and function of phospholipase A2
249. Mammalian non-pancreatic phospholipases A2
250. Mammalian calcium-independent phospholipase A2
251. Differential effects of ethanol on the expression of cyclo-oxygenase in cultured cortical astrocytes and neurons
252. Properties and regulation of cytosolic phospholipase A2
253. Characterization of human PLD2 and the analysis of PLD isoform splice variants
254. Role of phospholipase D-derived phosphatidic acid as a substrate for phospholipase A2 in RBL-2H3 cells
255. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins
256. Enhanced stimulatory effect of high density lipoproteins (HDL) and other agonists on vascular prostacyclin production in rats fed alcohol-containing diets
257. Acute and chronic effects of ethanol and its metabolites on vascular production of prostacyclin in rats
258. Induction of cyclooxygenase-2 in brain during acute and chronic ethanol treatment and ethanol withdrawal
259. Effect of ethanol on platelet phospholipase A2
260. Activation of arachidonic acid-specific phospholipase A2 in human neuroblastoma cells after chronic alcohol exposure: Prevention by GM1 ganglioside
261. Reduced tissue arachidonic acid concentration with chronic ethanol feeding in miniature pigs
262. Ethanol inhibits cytokine-induced iNOS and sPLA2 in immortalized astrocytes: Evidence for posttranscriptional site of ethanol action
263. The hydrolysis of phosphatidyl-alcohols by phospholipases A2: Effect of head group size and polarity
264. Phosphatidylethanol stimulates calcium-dependent cytosolic phospholipase A(2) activity of a macrophage cell line (RAW 264.7)
265. Families of phosphoinositide-specific phospholipase C: Structure and function
266. Inositol phospholipids-specific phospholipase C: Interaction of the gamma 1 isoform with tyrosine kinase
267. Chronic ethanol consumption disrupts complexation between EGF receptor and phospholipase C-gamma1: Relevance to impaired hepatocyte proliferation
268. Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling
269. Lipid-dependent activation of protein kinase C-alpha by normal alcohols
270. Phospholipase D
271. Phospholipase D: Enzymology, mechanisms of regulation, and function
272. GPI-specific phospholipase D associates with an apoA-I-and apoA-IV-containing complex
273. Glycosyl-phosphatidylinositol-specific phospholipase D. Interaction with and stimulation by apolipoprotein A-I
274. Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins
275. ADP-ribosylation factor 1 and its activation of phospholipase D are important for the assembly of very low density lipoproteins
276. Activation of endothelial cell phospholipase D by migrating neutrophils
277. Primary alcohols and phosphatidylcholine metabolism in rat brain synaptosomal membranes via phospholipase D
278. Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics
279. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: A possible role in cell proliferation and atherogenesis
280. Endothelin-1 is expressed and released by a human endothelial hybrid cell line (EA.hy 926)
281. Inhibition of astroglial cell proliferation by alcohols: Interference with the protein kinase C-phospholipase D signaling pathway
282. The influence of acute ethanol ingestion on phospholipase D activity in rat pancreas. An in vitro and in vivo study
283. Metabolic fate of [14C]-ethanol into endothelial cell phospholipids including platelet-activating factor, sphingomyelin and phosphatidylethanol
284. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia
285. Fatty acid ethyl esters increase rat pancreatic lysosomal fragility
286. Fatty acid ethyl esters decrease human hepatoblastoma cell proliferation and protein synthesis
287. Pancreatic injury in rats induced by fatty acid ethyl ester, a nonoxidative metabolite of alcohol
288. Fatty acid ethyl esters and HepG2 cells: Intracellular synthesis and release from the cells
289. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse
290. Fatty acid ethyl esters are present in human serum after ethanol ingestion
291. The distribution of fatty acid ethyl esters among lipoproteins and albumin in human serum
292. Long-term administration of highly purified eicosapentaenoic acid ethyl ester improves the dysfunction of vascular endothelial and smooth muscle cells in male WBN/Kob rats
293. Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress
294. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
295. Formation of malondialdehyde adducts in livers of rats exposed to ethanol: Role in ethanol-mediated inhibition of cytochrome c oxidase
296. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation
297. The chemistry and biological effects of malondialdehyde-acetaldehyde adducts
298. Inhibition of advanced glycation endproduct formation by acetaldehyde: Role in the cardioprotective effect of ethanol
299. Possible reasons why heavy drinking increases carbohydrate-deficient transferrin
300. Serum carbohydrate-deficient transferrin: Mechanism of increase after chronic alcohol intake
301. Effects of chronic ethanol on enzymes regulating sialylation and desialylation of transferrin in rats
302. Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls
303. The sialylation of plasma lipoproteins
304. The structures of the asparagine-linked sugar chains of human apolipoprotein B-100
305. All low-density lipoprotein particles are partially desialylated in plasma
306. Human very low density lipoproteins: Loss of electrophoretic mobility on enzymatic removal of sialic acid residues
307. Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content
308. Unaltered catabolism of desialylated low-density lipoprotein in the pig and in cultured rat hepatocytes
309. Sialic acid content of LDL and lipoprotein metabolism in combined hyperlipidemia and primary moderate hypercholesterolemia
310. Effect of sialic acid removal on human low-density lipoprotein catabolism in vivo
311. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients
312. Sialic-acid content of low-density lipoproteins controls their binding and uptake by cultured cells
313. The absence of a role for the carbohydrate moiety in the binding of apolipoprotein B to the low density lipoprotein receptor
314. Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease
315. LDL sialic acid content in patients with coronary artery disease
316. Sialic acid content of low-density lipoprotein in women with coronary artery disease
317. Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects
318. Sialic acid content of LDL in coronary artery disease: No evidence of desialylation in subjects with coronary stenosis and increased levels in subjects with extensive atherosclerosis and acute myocardial infarction: Relation between desialylation and in vitro peroxidation
319. Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a)
320. Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a)
321. High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": The role of kringle IV sequences in the extracellular association with low-density lipoprotein
322. Effect of desialylation on the biological properties of human plasminogen
323. Effect of lipoprotein(a) on lipid metabolism of cultured human intimal aortic cells
324. Alcohol and molecular regulation of protein glycosylation and function
325. Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver
326. Plasma catabolism of human apolipoprotein E isoproteins: Lack of conversion of the doubly sialylated form to the asialo form in plasma
327. Functional and structural properties of lipid-associated apolipoprotein J (clusterin)
328. Megalin and cubilin: Synergistic endocytic receptors in renal proximal tubule
329. Long-term ethanol exposure alters the sialylation index of plasma apolipoprotein J (Apo J) in rats
330. Deleterious actions of chronic ethanol treatment on the glycosylation of rat brain clusterin
331. O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins
332. Activation of lipoprotein lipase by apolipoprotein C-II is modulated by the COOH terminal region of apolipoprotein C-III
333. Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions
334. Cholesteryl ester transfer protein is secreted by Hep G2 cells and contains asparagine-linked carbohydrate and sialic acid
335. Modification of lipoprotein lipase catalytic activity by sialic acids
336. Transfer of phosphatidylethanol between high and low density lipoproteins
337. The endothelium and lipoproteins: Insights from recent cell biology and animal studies
338. Inhibition of phospholipase A(2) as a therapeutic target
339. Mitogenic effect of lipoproteins on human vascular smooth muscle cells: The impact of hydrolysis by gr II A phospholipase A(2)
340. Lipoprotein effects on the vessel wall
341. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins
342. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
343. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation
344. Chronic alcohol consumption increases serum levels of circulating endothelial cell/leucocyte adhesion molecules E-selectin and ICAM-1
345. How high-density lipoprotein protects against the effects of lipid peroxidation
346. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis
347. High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL
348. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion
349. Reconstituted discoid high-density lipoproteins increase the secretion of vascular endothelial growth factor from human vascular endothelial cells
350. Endothelial cells in physiology and in the pathophysiology of vascular disorders
351. Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury
352. Alcohol-induced upregulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cells
353. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein
354. Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation
355. Endothelial cell monolayer dysfunction caused by oxidized low density lipoprotein: Attenuation by oleic acid
356. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway
357. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma
358. Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression
359. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position
360. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells
361. Alcohol enhances oxysterol-induced apoptosis in human endothelial cells by a calcium-dependent mechanism
362. Very low-density lipoprotein activates nuclear factor-kappaB in
363. Apolipoprotein AI efficiently binds to and mediates cholesterol and phospholipid efflux from human but not rat aortic smooth muscle cells
364. Moderate alcohol feeding attenuates postinjury vascular cell proliferation in rabbit angioplasty model
365. Ethanol suppresses smooth muscle cell proliferation in the postprandial state: A new antiatherosclerotic mechanism of ethanol?
366. Ethanol inhibits basal and flow-induced vascular smooth muscle cell migration in vitro
367. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury
368. Expression of VCAM-1 in rabbit iliac arteries is associated with vasodilator dysfunction of regenerated endothelium following balloon injury
369. Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model
370. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1
371. Increased activity of endogenous endothelin in patients with hypercholesterolemia
372. Enhanced vasoconstrictor response to endothelin-B-receptor stimulation in patients with atherosclerosis
373. Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: Role of endothelin in macrophage foam cell formation
374. Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis
375. Role of endothelin-1 in atherosclerosis
376. Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells
377. Regulation of human monocyte functions by acute ethanol treatment: Decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production
378. Alcohol modulates alveolar macrophage tumor necrosis factor-alpha, superoxide anion, and nitric oxide secretion in the rat
379. The effects of alcohol on murine macrophage function
380. Ethanol-induced macrophage apoptosis: The role of TGF-beta
381. Ethanol feeding inhibits proinflammatory cytokine expression from murine alveolar macrophages ex vivo
382. Stimulation of phospholipase D activity by oxidized LDL in mouse peritoneal macrophages
383. Minimally modified low-density lipoprotein stimulates monocyte endothelial interactions
384. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase
385. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL